Clinical Trials Logo

Post-Operative Ileus clinical trials

View clinical trials related to Post-Operative Ileus.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06413888 Completed - Clinical trials for Delayed Gastric Emptying

Nasogastric Decompression Following Pancreaticoduodenectomy

whipple
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Pancreaticoduodenectomy (PD) remains the gold-standard operation for peri-ampullary neoplasms. Traditionally, gastric decompression via nasogastric intubation has been employed postoperatively to prevent nausea, vomiting, aspiration pneumonia, anastomotic leakage and delayed gastric emptying. Recently, the implementation of ERAS protocol recommended against routine use of nasogastric tube following PD. however, limited data exists surrounding the identification of those patients needing NGT decompression in the immediate postoperative period. Therefore, we initiated a large prospective randomized controlled trial to evaluate the clinical outcomes of patients who retained the NGT post-PD versus those who had it removed at the end of the procedure. This study aims to assess the effectiveness of nasogastric decompression in PD recovery, with the primary endo point being the need for and impact of NGT in the postoperative recovery. The secondary endpoint will examined the re-insertion rate of NGT and identify factors that necessitate its use in the immediate postoperative period.

NCT ID: NCT01869231 Completed - Clinical trials for Post-operative Ileus

Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus

Start date: April 2010
Phase: N/A
Study type: Interventional

Aim was to investigate efficacy of current treatments - water, chewing gum, and olive oil, in resolving postoperative ileus.

NCT ID: NCT01583452 Completed - Clinical trials for Post Operative Ileus

Chewing Gum Use to Reduce Post-operative Ileus in Pediatric Patients

Start date: April 2012
Phase: Phase 1
Study type: Interventional

Post- operative ileus refers to the time after surgery before coordinated electromotor bowel function resumes. It's treatment and prevention may signify an elevated hospitalization cost and the exposure to the patient to adverse effects of drugs. The current clinical trial has as primary objective to prove the efficacy of chewing gum as a preventive measure of post-operative ileus in pediatric patients after gastrointestinal surgery through the determination of the time the patient takes to tolerate oral intake, pass flatus, present bowel movements and the time of hospital stay. Patients will be assigned either to the case group (chewing gum + standard treatment) or to the control group (standard treatment), in both of them time from the end of surgery to the moment the patient presents first bowel movement, passes flatus, tolerates oral intake (any type of food) and is discharged from hospital; will be measured in hours and then analyzed to determine the validity of these data.